These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 32640410)

  • 1. Remedial dosing recommendations for delayed or missed doses of valproic acid in patients with epilepsy based on Monte Carlo simulations.
    Wang CY; Jiao Z; Ding JJ; Yu EQ; Zhu GX
    Epilepsy Behav; 2020 Oct; 111():107265. PubMed ID: 32640410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Remedial dosing recommendations for delayed or missed doses of lamotrigine in pediatric patients with epilepsy using Monte Carlo simulations.
    Yu EQ; Jiao Z; Wang CY; Ding JJ; Zhang XH
    Epilepsy Behav; 2019 Jul; 96():132-140. PubMed ID: 31132614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Managing delayed or missed pregabalin doses in patients with focal epilepsy: a Monte Carlo simulation study.
    Xie H; Zheng Y; Wang C; Song S; Dai Y; Huang X; Liu M; Wu X
    Int J Clin Pharm; 2024 Feb; 46(1):150-157. PubMed ID: 37991662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Handling Delayed or Missed Dose of Antiseizure Medications: A Model-Informed Individual Remedial Dosing.
    Li ZR; Wang CY; Lin WW; Chen YT; Liu XQ; Jiao Z
    Neurology; 2023 Feb; 100(9):e921-e931. PubMed ID: 36450606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Nonadherence on Levetiracetam Pharmacokinetics and Remedial Dose Recommendations Using Monte Carlo Simulations.
    Methaneethorn J
    Eur J Drug Metab Pharmacokinet; 2022 Sep; 47(5):667-676. PubMed ID: 35761145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Remedial Dosing Recommendations for Sirolimus Delayed or Missed Dosages Caused by Poor Medication Compliance in Pediatric Tuberous Sclerosis Complex Patients.
    Yang Y; Jiang L; Zhu HR; Sun WX; Mao JY; Miao JW; Wang YC; He SM; Wang DD; Chen X
    Curr Pharm Des; 2024; 30(11):877-886. PubMed ID: 38454763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of delayed and/or missed enteric-coated divalproex doses on valproic acid concentrations: simulation and dose replacement recommendations for the clinician.
    Dutta S; Reed RC
    J Clin Pharm Ther; 2006 Aug; 31(4):321-9. PubMed ID: 16882100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of poor compliance on the pharmacokinetics of carbamazepine and its epoxide metabolite using Monte Carlo simulation.
    Ding JJ; Zhang YJ; Jiao Z; Wang Y
    Acta Pharmacol Sin; 2012 Nov; 33(11):1431-40. PubMed ID: 23103621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How to handle a missed or delayed dose of lacosamide in pediatric patients with epilepsy? a mode-informed individual dosing.
    Wang J; Mei Y; Liang S; Li SC; Chen C; Nie G; Tuo YL; Sun D; Wang Y
    Epilepsy Behav; 2024 Feb; 151():109601. PubMed ID: 38194771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Population pharmacokinetics of unbound valproic acid in pediatric epilepsy patients in China: a protein binding model.
    Gu X; Zhu M; Sheng C; Yu S; Peng Q; Ma M; Hu Y; Li Z; Jiao Z; Zhou B
    Eur J Clin Pharmacol; 2021 Jul; 77(7):999-1009. PubMed ID: 33423079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Steady-state pharmacokinetic simulation of intermittent vs. continuous infusion valproic acid therapy in non-critically ill and critically ill patients.
    Van Matre ET; Cook AM
    Neurol Res; 2016 Sep; 38(9):786-91. PubMed ID: 27414414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Population Pharmacokinetic Evaluation and Missed-Dose Simulations for Eslicarbazepine Acetate Monotherapy in Patients With Partial-Onset Seizures.
    Sunkaraneni S; Blum D; Ludwig E; Chudasama V; Fiedler-Kelly J; Marvanova M; Bainbridge J; Phillips L
    Clin Pharmacol Drug Dev; 2018 Mar; 7(3):287-297. PubMed ID: 28881418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How to handle the delayed or missed dose of rivaroxaban in patients with non-valvular atrial fibrillation: model-informed remedial dosing.
    Liu XQ; Yin YW; Wang CY; Li ZR; Zhu X; Jiao Z
    Expert Rev Clin Pharmacol; 2021 Sep; 14(9):1153-1163. PubMed ID: 34058934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Model-based precision dosing and remedial dosing recommendations for delayed or missed doses of isoniazid in Chinese patients with tuberculosis.
    Li JM; Zhang RY; Yang GY; Cai QS; Lang YZ; Zhong FM; Huang JP; Chen YY; Qin Y; Fang LK; Ye B; Lin LH; Lin HH; Cai XJ; Xu K
    Br J Clin Pharmacol; 2024 Apr; ():. PubMed ID: 38570184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A population pharmacokinetic model taking into account protein binding for the sustained-release granule formulation of valproic acid in children with epilepsy.
    Rodrigues C; Chhun S; Chiron C; Dulac O; Rey E; Pons G; Jullien V
    Eur J Clin Pharmacol; 2018 Jun; 74(6):793-803. PubMed ID: 29564480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Once-daily dosing is appropriate for extended-release divalproex over a wide dose range, but not for enteric-coated, delayed-release divalproex: evidence via computer simulations and implications for epilepsy therapy.
    Reed RC; Dutta S; Liu W
    Epilepsy Res; 2009 Dec; 87(2-3):260-7. PubMed ID: 19892524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicted serum valproic acid concentrations in patients missing and replacing a dose of extended-release divalproex sodium.
    Reed RC; Dutta S
    Am J Health Syst Pharm; 2004 Nov; 61(21):2284-9. PubMed ID: 15552636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Population pharmacokinetics of levetiracetam and dosing recommendation in children with epilepsy.
    Chhun S; Jullien V; Rey E; Dulac O; Chiron C; Pons G
    Epilepsia; 2009 May; 50(5):1150-7. PubMed ID: 19175400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conversion from valproic acid onto topiramate in adolescents and adults with epilepsy.
    Schreiner A; Stollhoff K; Ossig W; Unkelbach S; Lüer W; Bogdanow M; Schauble B;
    Acta Neurol Scand; 2009 May; 119(5):304-12. PubMed ID: 19133865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Handling delayed or missed direct oral anticoagulant doses: model-informed individual remedial dosing.
    Liu XQ; Li ZR; Wang CY; Jiao Z
    Blood Adv; 2024 Sep; ():. PubMed ID: 39293087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.